Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Vladimir Vekstein, MD, is a staff physician in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute. He practices at Hillcrest Hospital where he is Director of the cardiac catheterization laboratory. He is board-certified in internal medicine, cardiovascular diseases and interventional cardiology.
Dr. Vekstein was appointed to the Hillcrest medical staff in 2000. Prior to that, he was director of the Coronary Care Unit at University Hospitals of Cleveland and Director of the Coronary Care Unit at The Mt. Sinai Medical Center from 1990 to 1997. He also was an assistant professor of medicine at Case Western Reserve University School of Medicine for 10 years, 1990 to 2000.
Dr. Vekstein earned his medical degree from New York University School of Medicine, New York, NY. He completed his residency in internal medicine and a fellowship in cardiology at Brigham and Women’s Hospital, Boston, Mass. During his cardiology fellowship he simultaneously completed a subspecialty fellowship in percutaneous transluminal coronary angioplasty.
After completing his postdoctoral training, Dr. Vekstein was an attending physician at Brigham and Women’s Hospital. He held this position until relocating to Cleveland in 1990.
Dr. Vekstein is the author of a number of papers, abstracts and reviews in leading cardiac journals, including Circulation, the New England Journal of Medicine and Journal of the American College of Cardiology. He has been a co-investigator on six studies related to heart attack and unstable angina and a co-principal investigator on a study of medications to treat acute heart attack.
In 2008, 2009 and 2010 Dr. Vekstein was named to the Best Physicians in Northeast Ohio list.
Coronary artery disease, myocardial infarction, coronary stents, congestive heart failure, valvular heart disease, hypertension and hyperlipidemia
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Vekstein's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.